A Subsidiary of Rostec Corporation and HTC ChemRar Launch a Joint Venture for Development and Manufacturing of the Next Generation of Antivirals in Russia and the Eurasian Economic Union

Read also

ChemDiv Extends CMC Services

ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials

EGFR Kinase Inhibitors for GFR Mutant Lung Cancer

ChemDiv’s Discovery Platform Enables Differentiated, Reversible Pan EGFR Kinase Inhibitors for GFR Mutant Lung Cancer

ChemDiv Continues R&D Services Support for Clywedog Therapeutics

San Diego, CA — September 30, 2025 — ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry,

ChemDiv Partnership with Mondego Bio

ChemDiv Extends Discovery and Early Development Partnership with Mondego Bio on Best-in-Class PTPN2 Immuno-Oncology Program